Table of Content




1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Drug Delivery Market
3.2. Development Of Drug Delivery System
3.3. Market Definition
3.4. Key Drivers
3.4.1. Growing Prevalence Of Respiratory Disease
3.4.2. Advancements In Technology
3.4.3. Rising Geriatric Population
3.5. Key Restraints
3.5.1. Stringent Regulation And Patent Expiry
3.5.2. Increasing Drug Recalls And Drug Failures
3.5.3. Side Effects And Risk Associated With The Drugs

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Impact Of Covid-19 On Pulmonary Drug Delivery Market
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights

5. Market By Application
5.1. Asthma
5.2. Chronic Obstructive Pulmonary Disease
5.3. Allergic Rhinitis
5.4. Cystic Fibrosis
5.5. Other Applications

6. Market By Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. E-Commerce

7. Market By End-User
7.1. Hospitals & Clinics
7.2. Homecare

8. Market By Product
8.1. Metered Dose Inhalers
8.2. Dry Powder Inhalers
8.3. Nebulizer
8.3.1. Pneumatic Nebulizer
8.3.1.1. Breath Actuated Pneumatic Nebulizer
8.3.1.2. Vented Pneumatic Nebulizer
8.3.2. Mesh Nebulizer
8.3.2.1. Vibrating Mesh Nebulizer
8.3.2.2. Static Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
8.4. Accessories

9. Geographical Analysis
9.1. North America
9.1.1. The United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. The United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Russia
9.2.6. Belgium
9.2.7. Poland
9.2.8. Rest Of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia & New Zealand
9.3.5. South Korea
9.3.6. Thailand
9.3.7. Indonesia
9.3.8. Vietnam
9.3.9. Rest Of Asia Pacific
9.4. Rest Of World
9.4.1. Latin America
9.4.2. Middle East & Africa

10. Company Profiles
10.1. 3M Company
10.2. Actelion Pharmaceuticals Ltd
10.3. Aerogen
10.4. Agilent Technologies Inc
10.5. Astrazeneca Plc
10.6. Boehringer Ingelheim Gmbh
10.7. Clement Clarke International
10.8. Gf Health Products Inc
10.9. Glaxosmithkline Plc
10.10. Koninklijke Philips Nv
10.11. Merck & Co Inc
10.12. Novartis Ag
10.13. Teva Pharmaceutical Industries Limited
10.14. Vectura Group Plc



List of Figures



List of Figures



Figure 1: Global Population, By Age Group 2015 & 2020 (In Million)
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: Global Pulmonary Drug Delivery Market, By Application, In 2019
Figure 7: Global Pulmonary Drug Delivery Market, By Asthma, 2019-2028 (In $ Million)
Figure 8: Global Pulmonary Drug Delivery Market, By Chronic Obstructive Pulmonary Disease, 2019-2028 (In $ Million)
Figure 9: Global Pulmonary Drug Delivery Market, By Allergic Rhinitis, 2019-2028 (In $ Million)
Figure 10: Global Pulmonary Drug Delivery Market, By Cystic Fibrosis, 2019-2028 (In $ Million)
Figure 11: Global Pulmonary Drug Delivery Market, By Other Applications, 2019-2028 (In $ Million)
Figure 12: Global Pulmonary Drug Delivery Market, By Distribution Channel, In 2019
Figure 13: Global Pulmonary Drug Delivery Market, By Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 14: Global Pulmonary Drug Delivery Market, By Retail Pharmacies, 2019-2028 (In $ Million)
Figure 15: Global Pulmonary Drug Delivery Market, By E-Commerce, 2019-2028 (In $ Million)
Figure 16: Global Pulmonary Drug Delivery Market, By End-User, In 2019
Figure 17: Global Pulmonary Drug Delivery Market, By Hospitals & Clinics, 2019-2028 (In $ Million)
Figure 18: Global Pulmonary Drug Delivery Market, By Homecare, 2019-2028 (In $ Million)
Figure 19: Global Pulmonary Drug Delivery Market, By Product, In 2019
Figure 20: Global Pulmonary Drug Delivery Market, By Metered Dose Inhalers, 2019-2028 (In $ Million)
Figure 21: Global Pulmonary Drug Delivery Market, By Dry Powder Inhalers, 2019-2028 (In $ Million)
Figure 22: Global Pulmonary Drug Delivery Market, By Nebulizer, 2019-2028 (In $ Million)
Figure 23: Global Nebulizer Market, By Pneumatic Nebulizer, 2019-2028 (In $ Million)
Figure 24: Global Pneumatic Nebulizer Market, By Breath Actuated Pneumatic Nebulizer, 2019-2028 (In $ Million)
Figure 25: Global Pneumatic Nebulizer Market, By Vented Pneumatic Nebulizer, 2019-2028 (In $ Million)
Figure 26: Global Nebulizer Market, By Mesh Nebulizer, 2019-2028 (In $ Million)
Figure 27: Global Mesh Nebulizer Market, By Vibrating Mesh Nebulizer, 2019-2028 (In $ Million)
Figure 28: Global Mesh Nebulizer Market, By Static Mesh Nebulizer, 2019-2028 (In $ Million)
Figure 29: Global Nebulizer Market, By Ultrasonic Nebulizer, 2019-2028 (In $ Million)
Figure 30: Global Pulmonary Drug Delivery Market, By Accessories, 2019-2028 (In $ Million)
Figure 31: North America Pulmonary Drug Delivery Market, Country Outlook, 2019 & 2028 (In %)
Figure 32: The United States Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 33: Canada Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 34: Europe Pulmonary Drug Delivery Market, Country Outlook, 2019 & 2028 (In %)
Figure 35: Germany Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 36: The United Kingdom Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 37: France Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 38: Italy Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 39: Russia Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 40: Belgium Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 41: Poland Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 42: Rest Of Europe Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 43: Asia Pacific Pulmonary Drug Delivery Market, Country Outlook, 2019 & 2028 (In %)
Figure 44: China Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 45: Japan Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 46: India Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 47: Australia & New Zealand Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 48: South Korea Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 49: Thailand Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 50: Indonesia Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 51: Vietnam Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 52: Rest Of Asia Pacific Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 53: Rest Of World Pulmonary Drug Delivery Market, Regional Outlook, 2019 & 2028 (In %)
Figure 54: Latin America Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)
Figure 55: Middle East & Africa Pulmonary Drug Delivery Market, 2019-2028 (In $ Million)


List of Tables



List of Tables



TABLE 1: MARKET SNAPSHOT - PULMONARY DRUG DELIVERY
TABLE 2: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL E-COMMERCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL E-COMMERCE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL HOMECARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL HOMECARE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL METERED DOSE INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL METERED DOSE INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL DRY POWDER INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL DRY POWDER INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL PNEUMATIC NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL PNEUMATIC NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL PNEUMATIC NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL PNEUMATIC NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL MESH NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL MESH NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL MESH NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL MESH NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL ULTRASONIC NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL ULTRASONIC NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION MARKET, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: REST OF WORLD PULMONARY DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: REST OF WORLD PULMONARY DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)